Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SD Head USA is the North American division of Shandong Head Group, a premier global manufacturer of cellulose ether products and plant-based capsules. The company specializes in pharmaceutical-grade excipients, including hydroxypropyl methylcellulose (HPMC), methyl cellulose (MC), and ethylcellulose (EC), which are critical for oral solid dosage forms and controlled-release drug delivery. As a vertically integrated producer, SD Head manages the entire supply chain from raw cellulose ether production to the manufacturing of empty HPMC capsules under its Healsee brand. In 2024, the company established an exclusive distribution partnership with Univar Solutions to expand its reach in the North American and European pharmaceutical and nutraceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SD Head.